Cargando…
The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells
Lysosomal replacement enzymes are essential therapeutic options for rare congenital lysosomal enzyme deficiencies, but enzymes in clinical use are only partially effective due to short circulatory half-life and inefficient biodistribution. Replacement enzymes are primarily taken up by cell surface g...
Autores principales: | Tian, Weihua, Ye, Zilu, Wang, Shengjun, Schulz, Morten Alder, Van Coillie, Julie, Sun, Lingbo, Chen, Yen-Hsi, Narimatsu, Yoshiki, Hansen, Lars, Kristensen, Claus, Mandel, Ulla, Bennett, Eric Paul, Jabbarzadeh-Tabrizi, Siamak, Schiffmann, Raphael, Shen, Jin-Song, Vakhrushev, Sergey Y., Clausen, Henrik, Yang, Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491494/ https://www.ncbi.nlm.nih.gov/pubmed/31040271 http://dx.doi.org/10.1038/s41467-019-09809-3 |
Ejemplares similares
-
Exploring the glycosylation of mucins by use of O-glycodomain reporters recombinantly expressed in glycoengineered HEK293 cells
por: Konstantinidi, Andriana, et al.
Publicado: (2022) -
Role of N-Glycosylation in FcγRIIIa interaction with IgG
por: Van Coillie, Julie, et al.
Publicado: (2022) -
A universal GlycoDesign for lysosomal replacement enzymes to improve circulation time and biodistribution
por: Chen, Yen-Hsi, et al.
Publicado: (2023) -
Installation of O-glycan sulfation capacities in human HEK293 cells for display of sulfated mucins
por: Sun, Lingbo, et al.
Publicado: (2021) -
Identification of global inhibitors of cellular glycosylation
por: Sørensen, Daniel Madriz, et al.
Publicado: (2023)